ZACHARY SMITH: Open Payments
NPI 1063126522 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,991 in 163 payments from 16 companies in 2025. Trend: 2023 $2,754 · 2024 $2,267 · 2025 $2,991
Food & beverage: $2,884Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $455 |
| Janssen Biotech, Inc. | 19 | $392 |
| GENZYME CORPORATION | 14 | $386 |
| Novartis Pharmaceuticals Corporation | 26 | $359 |
| Incyte Corporation | 15 | $253 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $241 |
| Regeneron Healthcare Solutions, Inc. | 9 | $228 |
| UCB, Inc. | 15 | $222 |
| LEO Pharma Inc. | 7 | $153 |
| Amgen Inc. | 2 | $53 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OPZELURA, COSENTYX, Bimzelx, RINVOQ, ILUMYA.
Industry payments across NY — which companies pay providers there.
